⌘K

Login Start Free

Home/Filings/4/0001610618-24-000135

4//SEC Filing

Tari Leslie 4

Accession 0001610618-24-000135

CIK 0001610618other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:27 PM ET

Size

5.5 KB

Accession

0001610618-24-000135

Insider Transaction Report

Form 4

Period: 2024-09-30

Cidara Therapeutics, Inc.CDTX

CHIEF SCIENTIFIC OFFICER

Transactions

Award
Employee Stock Option (right to buy)
2024-09-30+150,224→ 150,224 total
Exercise: $10.75Exp: 2034-09-29→ Common Stock (150,224 underlying)

Footnotes (1)

[F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of September 30, 2024.

Documents

1 file

4
wk-form4_1727904459.xmlPrimary
FORM 4

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1

filerCIK 0001870270

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 5:27 PM ET
Size: 5.5 KB

View on SEC.gov